Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Albuterol CFC Phase-Out Date Needed Now For HFA Ramp Up, Firms Says

Executive Summary

A lack of a definitive date for the phase-out of chlorofluorocarbon propelled albuterol metered dose inhalers could delay ramp up of production of inhalers that use non ozone depleting substances, manufacturers suggested at the June 10 meeting of FDA's Pulmonary-Allergy Drugs Advisory Committee

You may also be interested in...



CFC Albuterol To Be Pulled In 2008; FDA Says HFA Makers Need Ramp-Up Time

FDA is basing its Dec. 31, 2008 deadline for the withdrawal of CFC-containing albuterol on the concern that manufacturers will need additional time to ramp-up production of hydrofluoroalkane products

CFC Albuterol To Be Pulled In 2008; FDA Says HFA Makers Need Ramp-Up Time

FDA is basing its Dec. 31, 2008 deadline for the withdrawal of CFC-containing albuterol on the concern that manufacturers will need additional time to ramp-up production of hydrofluoroalkane products

GSK Offers Price Freeze On Ventolin HFA In Bid For Early Phase-Out Of CFCs

GlaxoSmithKline has offered to freeze the wholesale price of its Ventolin HFA inhaler as part of its case for FDA to phase out chlorofluorocarbon albuterol metered-dose inhalers by December 31, 2005

Related Content

UsernamePublicRestriction

Register

PS044138

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel